Nuveen Asset Management, LLC Eq Rx, Inc. Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.66 - $2.31 $4,037 - $5,617	-2,432 Reduced 0.3%	817,613 $1.82 Million
Q2 2023 Aug 14, 2023	BUY	$1.61 - $1.96 $242,741 - $295,511	150,771 Added 22.53%	820,045 $1.53 Million
Q1 2023 May 15, 2023	SELL	$1.8 - $2.83 $87,562 - $137,668	-48,646 Reduced 6.78%	669,274 $1.3 Million
Q4 2022 Feb 14, 2023	SELL	$2.05 - $5.5 $544,787 - $1.46 Million	-265,750 Reduced 27.02%	717,920 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $464,601 - $2.96 Million	494,257 Added 100.99%	983,670 $4.87 Million
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $1.57 Million - $2.78 Million	489,413 New	489,413 $2.3 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.